These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Intrahepatic cholangiocarcinoma: Morpho-molecular pathology, tumor reactive microenvironment, and malignant progression. Sirica AE; Strazzabosco M; Cadamuro M Adv Cancer Res; 2021; 149():321-387. PubMed ID: 33579427 [TBL] [Abstract][Full Text] [Related]
8. Oncogenic KRAS-expressing organoids with biliary epithelial stem cell properties give rise to biliary tract cancer in mice. Kasuga A; Semba T; Sato R; Nobusue H; Sugihara E; Takaishi H; Kanai T; Saya H; Arima Y Cancer Sci; 2021 May; 112(5):1822-1838. PubMed ID: 33068050 [TBL] [Abstract][Full Text] [Related]
9. Development and molecular composition of the hepatic progenitor cell niche. Vestentoft PS Dan Med J; 2013 May; 60(5):B4640. PubMed ID: 23673270 [TBL] [Abstract][Full Text] [Related]
10. Histopathology of a benign bile duct lesion in the liver: Morphologic mimicker or precursor of intrahepatic cholangiocarcinoma. Lee KB Clin Mol Hepatol; 2016 Sep; 22(3):400-405. PubMed ID: 27729636 [TBL] [Abstract][Full Text] [Related]
11. Case of an extra-large biliary intraductal papillary neoplasia. Madaleno R; Pissarra AP; Caseiro-Alves F BMJ Case Rep; 2019 Nov; 12(11):. PubMed ID: 31748374 [No Abstract] [Full Text] [Related]
12. Heterogeneity of the "oval-cell" response in the hamster liver during cholangiocarcinogenesis following Clonorchis sinensis infection and dimethylnitrosamine treatment. Lee JH; Rim HJ; Sell S J Hepatol; 1997 Jun; 26(6):1313-23. PubMed ID: 9210619 [TBL] [Abstract][Full Text] [Related]
13. Dysregulation of apoptosis in the cholangiopathies and cholangiocarcinoma. Celli A; Que FG Semin Liver Dis; 1998; 18(2):177-85. PubMed ID: 9606814 [TBL] [Abstract][Full Text] [Related]
14. Malignant Transformation Arising Within Unusual and Rare Hepatic Lesions: Fibropolycystic Disease Form of Ductal Plate Malformation and Biliary Adenofibroma. Chua D; Chiow AKH; Ang TL; Wang LM Int J Surg Pathol; 2018 Sep; 26(6):542-550. PubMed ID: 29464972 [TBL] [Abstract][Full Text] [Related]
15. Pathologic classification of cholangiocarcinoma: New concepts. Nakanuma Y; Kakuda Y Best Pract Res Clin Gastroenterol; 2015 Apr; 29(2):277-93. PubMed ID: 25966428 [TBL] [Abstract][Full Text] [Related]
16. Biliary adenofibroma: A rare hepatic lesion with malignant features. Kaminsky P; Preiss J; Sasatomi E; Gerber DA Hepatology; 2017 Jan; 65(1):380-383. PubMed ID: 27631648 [No Abstract] [Full Text] [Related]
17. Platelet-derived growth factor-D enables liver myofibroblasts to promote tumor lymphangiogenesis in cholangiocarcinoma. Cadamuro M; Brivio S; Mertens J; Vismara M; Moncsek A; Milani C; Fingas C; Cristina Malerba M; Nardo G; Dall'Olmo L; Milani E; Mariotti V; Stecca T; Massani M; Spirli C; Fiorotto R; Indraccolo S; Strazzabosco M; Fabris L J Hepatol; 2019 Apr; 70(4):700-709. PubMed ID: 30553841 [TBL] [Abstract][Full Text] [Related]